Abbas Ardehali
Direttore/Membro del Consiglio presso BIOM'UP
Posizioni attive di Abbas Ardehali
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOM'UP | Direttore/Membro del Consiglio | 30/01/2018 | - |
Medcura, Inc.
 Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Direttore/Membro del Consiglio | 01/06/2023 | - |
Storia della carriera di Abbas Ardehali
Formazione di Abbas Ardehali
| Emory University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Francia | 2 |
Posizioni
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Biom'Up SA
 Biom'Up SA Medical SpecialtiesHealth Technology Biom'Up SA engages in the development of hemostatic product composed of patent-protected biopolymers. Its products include Hemoblast Bellows and Hemosnow. The company was founded by Patricia Forest, Sylvain Picot and Christian Gagnieu on February 21, 2005 and is headquartered in Lyon, France. | Health Technology |
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Health Technology |
- Borsa valori
- Insiders
- Abbas Ardehali
- Esperienza